Join to view full profile
2650 Shawnee Mission PkwyMs 5003Westwood, KS 66205
Phone+1 913-588-6078
Fax+1 913-588-3996
Dr. Abdallah is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Al-Ola Abdallah is an Oncologist based in Westwood, KS with a subspecialty in Hematologic Oncology. He completed his fellowship in Hematology and Medical Oncology at the University of Arkansas for Medical Sciences in 2016, following a residency in Internal Medicine at University of Oklahoma School of Community Medicine (Tulsa). Dr. Abdallah completed his medical degree at the University of Jordan Faculty of Medicine in 2005. Since 2016, he has been employed by the University of Kansas Health System. He has authored various formally published papers in the field of Hematology, including in concepts of daratumumab in relapsed multiple myeloma and HLA-matched unrelated donor transplantation.
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Hematology and Medical Oncology, 2016
University of Oklahoma School of Community Medicine (Tulsa)Residency, Internal Medicine, 2007 - 2010
University of Jordan Faculty of MedicineClass of 2005
Certifications & Licensure
KS State Medical License 2016 - 2027
MO State Medical License 2021 - 2027
AR State Medical License 2011 - 2026
OK State Medical License 2009 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Hematology- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- MK-4002, a B-cell maturation antigen-targeting T-cell engager, in relapsed or refractory multiple myeloma: a first-in-human, open-label, phase 1 study.Sumit Madan, Caitlin Costello, Brea Lipe, Andrew J Cowan, Eva Medvedova
The Lancet. Haematology. 2026-10-06 - Noninterchangeability of Serum-Free Light Chain Assays at IMWG Thresholds: Analysis of 2117 Paired Samples.Asmi Chattaraj, Yue Yin, Kalaivani Babu, Srinishant Rajarajan, Santhosh Sadashiv
Clinical Lymphoma, Myeloma & Leukemia. 2026-08-19 - Outcomes After Matched Sibling Donor Versus Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis.Muhammad Umair Mushtaq, Amir Kasaeian, Tahereh Rostami, Muhammad Kashif Amin, Shayan Forghani
Transplantation and Cellular Therapy. 2026-08-18
Press Mentions
Kansas University Cancer Center Offering New Treatment so Patients 'Can Enjoy Your Life'March 24th, 2026- The University of Kansas Health System: Life-Changing Cancer BreakthroughsOctober 1st, 2026
- The University of Kansas Health System: Life-Changing Cancer BreakthroughsOctober 2nd, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: